Clincosm LogoSign in Get a demo

Alzheimer Disease

Showing NaN - NaN of 84
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Worldwide (Donanemab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Hoover, Alabama
  • +282 more
Apr 6, 2022

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Recruiting
  • Early Onset Alzheimer Disease
  • +2 more
  • Sun City, Arizona
  • +18 more
Mar 15, 2022

Alzheimer Trial in New York (MW150, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • New York, New York
    Columbia University Irving Medical Center
Mar 13, 2022

Autoimmune Features of Neurodegenerative Disorders

Recruiting
  • Parkinson Disease
  • +2 more
    • New York, New York
      Columbia University Medical Center
    Mar 8, 2022

    Alzheimer Trial in Australia, United States (ATH-1017)

    Enrolling by invitation
    • Alzheimer Disease
    • Sun City, Arizona
    • +35 more
    Feb 28, 2022

    Alzheimer Trial in New York (procedure, other, behavioral)

    Recruiting
    • Alzheimer Disease
    • Nocturnal polysomnography (NPSG)
    • +3 more
    • New York, New York
    • +1 more
    Feb 18, 2022

    11C-PIB PET Study in MESA at Columbia University

    Enrolling by invitation
    • Cognitive Impairment
    • +3 more
    • New York, New York
      Columbia University Irving Medical Center
    Feb 2, 2022

    Alzheimer Trial in United States (troriluzole, Placebo oral capsule)

    Completed
    • Alzheimer Disease
    • Phoenix, Arizona
    • +43 more
    Feb 15, 2022

    Alzheimer, Alzheimer, Late Onset, Memory Loss Trial in New York (Web-based education)

    Recruiting
    • Alzheimer Disease
    • +3 more
    • Web-based education
    • New York, New York
      Weill Medical College of Cornell University
    Jan 28, 2022

    Alzheimer Trial in New York (11C-ER176, 18F-florbetaben)

    Recruiting
    • Alzheimer Disease
    • New York, New York
      Columbia University Irving Medical Center
    Jan 10, 2022

    Alzheimer Trial in New York (Disclosure of APOE genotype)

    Recruiting
    • Alzheimer Disease
    • Disclosure of APOE genotype
    • New York, New York
      Columbia University Irving Medical Center
    Jan 19, 2022

    Accelerated Non-Atherosclerotic Brain Arterial Aging

    Recruiting
    • Alzheimer Disease
    • Dementia
    • New York, New York
      Columbia University Medical Center
    Jan 11, 2022

    Alzheimer Trial in New York, Philadelphia (CT1812, Placebo)

    Completed
    • Alzheimer Disease
    • New York, New York
    • +1 more
    Jan 10, 2022

    Dementia Subjects With Agitation

    Completed
    • Dementia
    • +5 more
      • Tucson, Arizona
      • +1 more
      Dec 16, 2021

      Alzheimer Trial in United States (AMX0035, Placebo)

      Completed
      • Alzheimer Disease
      • Jacksonville, Florida
      • +10 more
      Nov 10, 2021

      Alzheimer Trial in Worldwide (neflamapimod, )

      Completed
      Has Results
      • Alzheimer Disease
      • Long Beach, California
      • +37 more
      Sep 28, 2021

      Healthy, Alzheimer Trial in Australia, United States (AL003, Saline Solution)

      Completed
      • Healthy
      • Alzheimer Disease
      • AL003
      • Saline Solution
      • Delray Beach, Florida
      • +5 more
      Sep 15, 2021

      Late Onset Alzheimer's Disease

      Recruiting
      • Alzheimer Disease
      • Blood Draw
      • Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test
      • Washington, District of Columbia
      • +11 more
      Aug 11, 2021

      Alzheimer Trial in New York (18F-MK-6240, Lumbar Puncture (optional))

      Recruiting
      • Alzheimer Disease
      • New York, New York
        Columbia University Medical Center
      Aug 4, 2021

      Alzheimer Trial in New York (11C-ER176, Florbetaben)

      Enrolling by invitation
      • Alzheimer Disease
      • New York, New York
        Columbia University Medical Center
      Aug 4, 2021

      Alzheimer Trial in New York (11C-ER176, 18F-MK6240, 18F-Florbetaben)

      Recruiting
      • Alzheimer Disease
      • New York, New York
        Columbia University Irving Medical Center
      Jul 28, 2021

      Alzheimer Trial in New York (18F-MK-6240, 18F-Florbetaben)

      Enrolling by invitation
      • Alzheimer Disease
      • New York, New York
        Columbia University Medical Center
      Jul 30, 2021

      Alzheimer Trial in New York (18F-MK-6240, 11C-PIB)

      Enrolling by invitation
      • Alzheimer Disease
      • New York, New York
      • +1 more
      Jul 8, 2021

      Stroke, Parkinson Disease, Multiple Sclerosis Trial in Finland, United States (Dysphagia Detection System)

      Terminated
      Has Results
      • Stroke
      • +5 more
      • Dysphagia Detection System
      • Downey, California
      • +12 more
      Apr 29, 2021

      Elderly, Alzheimer Trial in New York (Actigraphy, Nocturnal Polysomnograpahy (NPSG))

      Completed
      • Elderly
      • Alzheimer Disease
      • Actigraphy
      • Nocturnal Polysomnograpahy (NPSG)
      • New York, New York
        New York University School of Medicine
      Feb 23, 2021